The XSurgical Robotics offering is now closed and is no longer accepting investments.

XSurgical Robotics

Surgical Robotics, Reinvented

XSurgical Robotics

Surgical Robotics, Reinvented

Cambridge, MA
Health Tech
XSurgical plans to take to market what Management believes to be the first surgical robot capable of both operating in hospitals and portable in the open field, integrating minimally invasive, open surgery and orthopedic procedures.

$44,616

raised
112
Investors
$25M
Valuation
$4.00
Price per Share
$100.00
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left

$44,616

raised
112
Investors
$25M
Valuation
$4.00
Price per Share
$100.00
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left
This offering ended on April 21, 2022 and is no longer accepting investments.

Reasons to Invest

XSurgical is creating an entirely new market segment through the novel paradigm developing a robot capable of performing a wide variety of procedures reaching a bigger number of hospitals and open field applications.
We are aiming to serve about 3% of a $15 Billion market. Approximately $6 million of funding deployed into our company to date.
We believe XSurgical’s Robot is unique in that it is designed to be the first Open Architecture Surgical Robot, enabling third parties to implement their tools and procedures for our platform.

Overview


Surgical Precision Where it’s needed Most


XSurgical is committed to bringing the technology of robotic surgery to a whole new level. 


Our firm is currently developing a natively remotely controlled surgical robot employing AI - which can not only operate in a hospital like its competitors, but be deployed also in situations of disaster recovery and battlefields.  


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


This technology will bring the expertise and skills of a top surgeon to perform complex, surgical procedures in remote locations. 



Currently, we are working on the third iteration of our robot, the Gamma, at our laboratory in Cambridge MA.


All in all, we are here to move the technology forward. We are ready to bring that vision into an ever-expansive market. 


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


The Problem


Surgical Robots are Expensive and Limited


Today’s surgical robots are used only in the top 5,000 hospitals in the world. Those current vendors neglect the other 50,000 that have the same clinical needs of large hospitals - mostly because they cannot afford the costs of current solutions.


Not to mention, most robots today can perform only a very limited number of procedures. As a consequence, only the largest hospitals in major towns can ensure a steady volume of patients that can benefit from the technology, while the vast majority of the global population can not be reached (or would have to afford to go where it’s possible).



We believe XSurgical will deliver a more versatile solution that will enable more surgeons to execute more procedures with increased precision, filtered tremor, increased dexterity, scalable movements, and more (think about all the procedures where it is required the use of magnification lopes but the hands movement is not equally scaled).  


We believe that this will result in significant improvements in the overall quality of health care. 

The Market


Entering a Billion-Dollar Untapped Opportunity 


There is general consensus in the industry that the surgical robotic market should exceed $15 Billion globally at maturity. In fact, Bank of America Merrll Lynch is estimating that just the U.S. market alone should exceed $18 Billion - addressing more than 6 Million procedures per annum. (Source)



In addition to the initial capital equipment sale, we believe that the average value per unit sold is higher than $2 million, leading to a Total Addressable Market of more than $15 Billion. (Source)


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


XSurgical is uniquely positioned to serve this $ 1.6 Billion untapped opportunity. We plan to develop a new universal platform for surgical robotics that we believe will be the first able to serve both the Open Field and the 50,000 hospitals currently neglected by competitors.



The Solution


We Move the Technology, Not the Patients


XSurgical Gamma Robot is designed as a Universal Surgical Robot - capable of performing a high number of procedures just by adopting a proper set of instruments and tools. 


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


This enables the use of a single Robot to perform many different kinds of procedures, and it can be shared between multiple departments such as...



We believe XSurgical’s Robot is unique in that it is designed to be the first Open Architecture Surgical Robot. This means we enable third parties to implement their own procedures (Surgical Instruments, Software and Protocols) and sell their upgrades for our native platform (paying royalties for XSurgical). 


The idea is to “crowdsource” the effort of implementing a wide range of procedures. To further support its partners, XSurgical is implementing a XDK (XSurgical Development Kit) which includes mechanical drawings, electric diagrams, software to enable third parties to implement their procedures for our platform.



Our universal surgical robot is capable of:


  • Operating on both within hospitals and in the open field
  • Integrating both minimally invasive and open surgery procedures
  • Equally effective on soft tissues (e.g. abdominal) and hard tissues (e.g. orthopedics)
  • Creating an open platform enabling surgeons to use their preferred tools and systems on our robots
  • Making tele-operation real in both execution and supervision of surgical procedures
  • Enabling an effective sharing of assets among regional hospitals
  • Fast and easy deployment and set-up, enabling robotic execution for a much higher number of procedures
  • Significantly reducing the cost per robotic procedures thanks to better assets utilization and increased tool operating life
  • Making surgical robotics available and affordable for the vast majority of hospitals, including those in developing countries


We believe our Robot is the first and only to be designed for multiple types of surgery. Furthermore, we think our system will be the only surgical robot designed to operate not only in a hospital environment, but also for mobile settings.


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


The revenues will be generated by:

  • Robot sales
  • Service Maintenance
  • Disposable Instruments and parts
  • System extension packages
  • Third parties royalties

Why Invest


Our Vision is to Build Surgical Robots that Will Aid All Hospitals and Beyond


We believe we are 3 years away from the market. As a first step, we will be completing the prototypes that will be used for FDA approval and CE marking. We may be able to generate revenues earlier from military contracts, and within 10 years, we plan to be key players in a $15 billion industry. 


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


The surgical robots of the future have to be much easier to use -  capable of assisting a surgeon in speeding up their job, and avoid creating higher treatment costs. Also the convergence of AI means lower costs for high computation power, faster telecommunication networks, and more. 


*Images used in this video are in the prototype phase, the AI Surgical Robot is not currently available on the market.


We want to be pioneers in this field and deploy today smart and effective surgical robotic solutions and probably AI-supported surgical robots for the next decade.

In the Press

Medical Design Briefs

Taking Advanced Surgical Robotics Beyond the Surgical Suite

WCVB5

Bringing the skills of doctors to cutting edge robots. Cutting Edge Interview with Gianluca De Novi, PhD.

MDDI Online

Where's Robotic-Assisted Surgery Headed? Innovators in surgical robotics shared their perspectives at MD&M East’s Medtech Education Hub.

OR Today

XSurgical Welcomes U.S. Department of Defense’s Dr. Darrin Frye as Speaker

Boston City Biz List

XSurgical Hosts Officials; DOD at Ribbon Cutting for new International HQ in Cambridge, MA.

EIN Press Wire

XSurgical Hosts Officials. Department of Defense at Ribbon Cutting for new International HQ in Cambridge, Massachusetts.

Dell Technologies

Remote-Controlled Robotic Surgery? Yup, It’s Happening.

MDDI Online

XSurgical Touts MTEC Membership and Future in Surgical Robotics

Offering Summary


Company

:

XSurgical Inc.

Corporate Address

:

701 Concord Ave, Ste 201, Cambridge, MA 02138

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,070,000.00

Minimum Investment Amount

(per investor)

:

$100.00











Terms


Offering Type

:

Equity

Security Name

:

Series A 1 Preferred Stock

Minimum Number of Shares Offered

:

2,500

Maximum Number of Shares Offered

:

267,500

Price per Share

:

$4.00

Pre-Money Valuation

:

$25,000,000.00











*Maximum number of shares offered subject to adjustment for bonus shares. See bonus info below.

Company Perks*

Early Bird

Friends and Family - First 72 hours | 15% bonus shares

Super Early Bird - Next 72 hours | 10% bonus

Early Bird Bonus - Next 7 days | 5% bonus shares

Volume

Tier 1 perk - ($1,000+ 1% bonus shares)

Tier 2 perk - ($5,000+ 2% bonus shares)

Tier 3 perk - ($10,000+ 3% bonus shares)

Tier 4 perk - ($25,000+ 5% bonus shares)

Tier 5 perk - ($50,000+ 10% bonus shares) and invitation to the Investors Club meetings, which will be held twice a year (virtually) with the participation of the Board and key advisors

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

XSurgical Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Preferred Stock at $4.00 / share, you will receive 10 additional shares of Common Stock, meaning you'll own 110 shares for $400. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are cancelled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Inter company debt or back payments. Salary payments made to one’s self, a friend or relative.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$132,467.00 USD
$210,170.00 USD
Cash And Cash Equivalents
$2,467.00 USD
$70,170.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$39,412.00 USD
$0.00 USD
Long Term Debt
$323,859.00 USD
$308,438.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$134,787.00 USD
-$210,843.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Final Day to Get your Shares of XSurgical Robotics

2 months ago

Time flies... it was a short ride and we have learned a lot.

Here we are, did you get a piece of our dream? if you did, get more... if you didn't this is the last opportunity to get some more on Start Engine.

We are excited for the new fellow shareholders that will follow us on our journey and we are looking forward to seeing more and more investors joining our mission.

Thank you to everyone.

Gianluca De Novi, Ph.D.

-5 to campaign ending!!!

3 months ago

- 5 days to the end of our crowdfunding campaign.

If you didn't get your shares, please do it! 

We are excited to close this campaign in a successful way.


Thanks,

XSurgical Robotics Team

Technical issues for the re-confirmation after campaign Extension

3 months ago

Dear Investors,

It appears to us that some of you didn't receive the request to reconfirm the initial investment in XSurgical when we extended our campaign with the direct result to have the investment canceled.

Please, be advised that if this is the case, the best course of action is to reconfirm the investment and contact Start Engine to inform them about the missed notification.

We sincerely apologize for these technical difficulties that together with some others have been contributing to the lack of timely communication and sometimes the loss of the investment. We are working with the team of Start Engine to ensure that there will be support for whoever suffered these circumstances.

Sincerely

XSurgical Robotics Team

XSurgical is accepting Investments again

3 months ago

Dear Investors,

We have extended our crowdfunding campaign for one more month. We thank each one of the investors that have reconfirmed the investment in XSurgical and we'll miss the ones that have changed their minds.


Thank you for continuing to support us,

XSurgical Robotics Team

Notice of Material Change in Offering

4 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the XSurgical Robotics offering. Here's an excerpt describing the specifics of the change:


Issuer is extending campaign to 4/20/22.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

XSurgical Reaches $50K Milestone!

5 months ago

Greetings,

Big shoutout and thanks to our initial investors from the entire XSurgical Robotics team!

With your support, we just reached $50K on StartEngine in about 40 days since the beginning of our campaign.

That’s one good start and this will give to XSurgical the opportunity to reach even more investors.

Now, we’re ready to keep the ball rolling, reaching one by one all the development milestones!

Our mission is to try and advance the standard of care in surgical robotics with innovative technology solutions that can reach the entire global population rather than serve only those who live in proximity of large hospitals.


With your support, we know we can do it.

Become a shareholder today and let's democratize access to this technology!



XSurgical will attend the "Military Health System Research Symposium 2022"

5 months ago

The MHSRS is the Department of Defense’s foremost scientific meeting. It provides a venue for presenting new scientific knowledge resulting from military-unique research and development. The MHSRS is the premier military or civilian meeting that focuses specifically on the unique medical needs of the Warfighter.

The MHSRS provides a collaborative setting for the exchange of information between military providers with deployment experience, research and academic scientists, international partners, and industry on research and related health care initiatives falling under the topic areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, Medical Simulation and Information Sciences, Military Infectious Diseases, and the Radiation Health Effects.

The MHSRS is an annual four-day educational symposium that draws approximately 3,500 attendees.

At the current time, the management of XSurgical has decided to submit an abstract to the conference and to send some representatives to engage in networking, business development and meet the "old friends" maintaining the existing relationships sharing at the same time all the updates about the company and our technology development.

We are thrilled to be at MHSRS after two years of absence due to COVID cancellations.

Happy New Year!

6 months ago

I'd like to personally thank all the investors that joined us in these past few days of 2021. 

The year 2022 is going to be a very important year for us and we hope that our fundraising will be successful enough to allow us to move fast toward our final design of the Gamma Robot. 

We are proud to have you on board and we are looking forward to sharing any achievements with you.

We have ambitious goals but most importantly the determination, the motivation, and the passion for getting us through the finish line soon.


Have a wonderful 2022 guys!

Gianluca De Novi, PhD

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}